Healthcare

AcelRx is a specialty pharmaceutical company focused on developing and commercializing innovative therapies. What's ACRX's stock forecast?

Oren Frank and his wife, Roni Frank, founded Talkspace as a solution for people in need of mental health help. So, who is Oren Frank?

Elizabeth Holmes, the shamed founder of defunct health tech startup Theranos, faces criminal fraud charges. Is she still a billionaire?

In the last year, T2 Biosystems stock has risen 36 percent. Is TTOO stock a good buy at this price? How's the company's outlook and what can investors expect?

Vegan oat milk brand Oatly may pursue an IPO in 2021, potentially raising $1 billion.

Clover Health plans to merge with Social Capital Hedosophia Holdings. Which business is Clover Health into and how does it makes money?

The Pfizer vaccine, though not a live virus, requires extremely cold storage to prevent its genetic material from breaking down.

AstraZeneca is a leading biopharmaceutical company that focuses on developing drugs to treat cancer, heart disease, and COPD. What drugs does the company make?

There were a total of six deaths in the late-stage clinical trial for Pfizer’s COVID-19 vaccine. So, is Pfizer’s COVID-19 vaccine safe and effective?

Peloton stationary bikes cost upwards of $2,000 and require a monthly subscription. Why is Peloton so expensive?

Green energy and marijuana stocks have rallied after Biden's election. What are the best cannabis stocks to buy for 2021?

Biogen, which is an American multinational biotechnology company, was the S&P 500’s top loss on June 18.

Vertex Pharmaceuticals (VRTX) reported its 2Q16 earnings on July 27, 2016. VRTX surpassed Wall Street analysts’ projections and reported revenue of $431.6 million.

Ireland-based Covidien is a global healthcare leader that offers innovative medical technology solutions and patient care products to providers.

FLIR Systems was the S&P 500’s top gainer on July 25. FLIR Systems opened higher on July 25 and rose to record high price levels.

AbbVie (ABBV) generated net revenue of $7.9 billion in 1Q18 compared to $6.5 billion in 1Q17.

UnitedHealth Group is a leading managed healthcare firm in the United States.

Chilton started a new position in aerospace engineering company TransDigm Group Inc. (TDG) that accounts for 0.76% of the fund’s fourth quarter portfolio.

Approximately 63% of Wyndham’s revenues come from fees for providing services referred to as its “fee-for-service” businesses.

Pershing Square disclosed a new position in Platform Specialty Products (PAH) that accounts for 7.58% of Pershing Square’s 1Q14 portfolio.

Spark Therapeutics’ (ONCE) operating expenses decreased from $78.48 million in Q2 2017 to $59.78 million in Q2 2018.

It's official — lab-grown meat has made its way to the market. Eat Just has achieved regulatory approval in Singapore. Can you invest in lab-grown meat stock?

Since Teladoc acquired Livongo, the shares fall under a new umbrella. What happened to Livongo stock after the merger?

Butterfly Network, a digital health company, is about to go public through a SPAC IPO. When is its IPO date?

Xtandi is the major factor behind Pfizer’s (PFE) interest in Medivation (MDVN). The drug, along with MDVN’s pipeline molecules, should strengthen Pfizer’s (PFE) oncology franchise.

On September 14, Boston Scientific (BSX) was trading at a forward price-to-earnings ratio of 24.4x, compared to the industry’s average PE ratio of 22.4x.

The company has delivered a robust financial performance in recent quarters. However, the stock has been on a bearish trend during the recent period.

Medivation’s portfolio complements Pfizer’s existing oncology portfolio that includes solid tumors, hematology, and immunology-oncology.

Boston Scientific (BSX) announced the acquisition of Veniti for $108.0 million. BSX already owns a 25% stake in Veniti.

In 2Q17, Inlyta generated revenues of ~$88 million, which represents an ~19% decline on a YoY basis and ~4% growth on a quarter-over-quarter basis.

In this series, we’ll get down to the brass tacks of investing in the REIT sector, the market’s current landscape, and the benefits you can expect from this type of investment.

Increased life expectancy means a longer investment horizon. With life expectancy increasing, young investors should invest in equities aggressively.

Ligand Pharmaceuticals has developed a product portfolio that spans more than 700 patents offering varying degrees of protection to the assets.

Global monetary policy is unconventional. From an era of lowering interest rates to boost economic growth, central bankers are taking rates into negative territory.

In its Structural Heart business, Abbott Laboratories reported 1Q18 sales of $0.29 billion, registering YoY organic sales growth of 7.5%.

For fiscal 2018 (ended March 31, 2018), Abiomed (ABMD) has projected that its operating margins will be in the range of 22%–24%.

Alnylam Pharmaceuticals (ALNY) is currently developing three investigational therapies—Patisiran, Revusiran, and ALN-TTRsc02—for the treatment of patients with hereditary ATTR amyloidosis.

Today, Teva Pharmaceutical Industries (TEVA) announced that its Granix (tbo-filgrastim) injection has received FDA approval for a new presentation and indication.

23.1% of analysts gave United Therapeutics (UTHR) a “buy” recommendation while 69.2% of analysts rated the company a “hold.”

Stock performance In this article, we’ll discuss the year-to-date (YTD) stock performance of ConocoPhillips (COP), Devon Energy (DVN), Occidental Petroleum (OXY), Anadarko Petroleum (APC), and EOG Resources (EOG), which reported the highest revenue among upstream companies in fiscal 2017. Outliers and underperformers The above image shows that ConocoPhillips (COP) is the outlier among peers. YoY […]